Evotec SE (OTCMKTS:EVTCY – Get Free Report) shares crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $3.28 and traded as low as $3.12. Evotec shares last traded at $3.12, with a volume of 77,568 shares.
Evotec Price Performance
The stock has a 50 day moving average of $3.26 and a two-hundred day moving average of $3.65. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57. The firm has a market capitalization of $1.02 billion, a P/E ratio of 7.51 and a beta of 0.98.
About Evotec
Evotec SE is a Germany-based biotechnology company specializing in drug discovery alliance and development partnerships. Headquartered in Hamburg, the company collaborates with pharmaceutical and biotechnology firms to deliver integrated solutions across the drug discovery and development continuum. Its offerings span from target identification and validation to lead optimization, preclinical development and manufacturing support.
The company’s platform combines expertise in assay development, high-throughput screening, medicinal chemistry, in vivo pharmacology and safety assessment.
Recommended Stories
- Five stocks we like better than Evotec
- But this $2 Gold Stock Before May 20, 2026
- Trump’s new AI budget just passed — one stock could soar
- Do not delete, read immediately
- BNZI Posts Record Q3 Revenue – See What’s Driving It.
- GOLD ALERT
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
